Current location:entertainment >>
Lilly rides Mounjaro, Zepbound to better
entertainment5986People have gathered around
IntroductionRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, ...
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Stellar Space news portal”。http://iceland.downmusic.org/html-48b599937.html
Related articles
Chinese women's national football team seeks head coach
entertainment(ECNS) -- The Chinese Football Association issued a notice on Tuesday, seeking to recruit a head coa ...
Read moreChina records nearly 5 bln domestic trips in 2023
entertainmentA total of 4.89 billion domestic trips were made in China in 2023, marking a year-on-year increase o ...
Read moreEnterprises bullish on supply chain expo
entertainmentBoth domestic and foreign companies are highly enthusiastic about participating in the second China ...
Read more
Popular articles
Latest articles
LINKS
- Ruling sparks debate on AI technology
- Xi Focus: Xi Stresses Healthy, High
- Washington moves seen as risking instability
- COP28 sets eyes on AI to fight climate change
- Xi Focus: China Pursues Development for People's Well
- Ruling sparks debate on AI technology
- Highlights of Xi and Putin's Talks in Russia
- Xi Signs Presidential Order to Appoint Li Qiang as Premier
- China's National Legislators Start to Elect Chinese President, Other State Leaders
- Asian regional cooperation highlighted at security meeting